Literature DB >> 29051895

Chronic Lymphocytic Leukemia: A Rare Cause of Pathological Fracture of the Femur.

Parita Soni1, Nidhi Aggarwal1, Anand Rai1, Vivek Kumar1, Kamholz Stephan1, Yoon Taek1, Kupfer Yizhak1.   

Abstract

The incidence rate of chronic lymphocytic leukemia (CLL) in the United States is approximately 0.005%; men are at slightly higher risk than women. Bony involvement or pathological fracture rarely occurs in CLL, and it may be the initial presentation. An 85-year-old woman presented with acute respiratory failure secondary to pneumonia. Symptomatology included dyspnea. She was found to have pathological fracture of the femur caused by CLL. The diagnosis of CLL had been made 6 years previously, but the patient had refused therapy. On admission, the patient required endotracheal intubation, mechanical ventilation, and admission to the medical intensive care unit. Endotracheal intubation extubation was successful after 48 hours. The patient then complained of severe left knee pain. Bone radiograph and femoral computed tomography scan revealed acute pathological fracture of the left distal femur. There was no history of trauma. The fracture was stabilized with extension lock splint. Pathological fracture in patients with CLL is associated with hypercalcemia, Richter's transformation, or multiple myeloma. This patient exemplifies the fact that pathological fracture can be caused by CLL in the absence of hypercalcemia, Richter's transformation, or multiple myeloma and can be the initial presentation of CLL.

Entities:  

Keywords:  Richter’s transformation; chronic lymphocytic leukemia; hypercalcemia; multiple myeloma; pathological fracture

Year:  2017        PMID: 29051895      PMCID: PMC5637973          DOI: 10.1177/2324709617735135

Source DB:  PubMed          Journal:  J Investig Med High Impact Case Rep        ISSN: 2324-7096


Introduction

Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disorder mainly affecting older adults. The average age at diagnosis is 71 years.[1] CLL accounts for one quarter of the new cases of leukemia and affects every 1 in 200 persons (about 0.005%) in the United States.[2] The presentation varies from completely asymptomatic to the eventual development of anemia, thrombocytopenia, and infections due to involvement of lymph nodes, spleen, and liver. Bony involvement in leukemia is most commonly associated with acute lymphoblastic or acute myeloblastic leukemia.[3] CLL leading to pathological fracture is a rare phenomenon.[4] We present a patient with stage III CLL causing a pathological fracture of the distal femur.

Case Presentation

An 85-year-old Caucasian woman presented to the emergency department with shortness of breath. She was diagnosed with CLL 6 years ago, and she also had atrial fibrillation, chronic heart failure, and hypertension. She had refused therapy at the time of initial diagnosis. On presentation, temperature was 101.3°F, heart rate 130/min, respiratory rate 32/min, blood pressure 156/67 mm Hg, and SpaO2 80% on ambient air, which improved minimally after the institution of BiPAP. In the emergency department, the patient was intubated because of acute respiratory failure and sepsis secondary to pneumonia. She was admitted to the medical intensive care unit and was successfully extubated after 2 days of treatment. Laboratory work data included white blood cells count 107 000/µL, hemoglobin 10.4 g/dL, and platelets 149 000/µL. Peripheral smear revealed 2+ smudge cells and more than 7 atypical lymphocytes per oil immersion field (Figure 1). Electrolyte panel was within normal limits. Bone marrow examination revealed no signs of Richter’s transformation or multiple myeloma. The patient refused treatment for CLL in the past but intravenous immunoglobulin therapy was instituted because of the risk of serious infectious complications.
Figure 1.

Peripheral smear (60×) showing small lymphocytes and smudge cells (arrows).

Peripheral smear (60×) showing small lymphocytes and smudge cells (arrows). On hospital day 3, she began complaining of severe left knee pain. She denied any trauma or fall. The left knee was warm and extremely tender to touch. Arthrocentesis excluded the possibility of septic arthritis. Bone radiograph demonstrated an acute pathological fracture of the left distal femur. This finding was confirmed by computed tomography of the left knee (Figure 2).
Figure 2.

Enhanced computed tomography of the left knee showing acute pathological fracture of the left distal femur (arrows).

Enhanced computed tomography of the left knee showing acute pathological fracture of the left distal femur (arrows). Although open reduction internal fixation is the treatment of choice, it was not recommended because of her limited prognosis attributable to the nature of the fracture, severe osteopenia, and other comorbidities. The patient was treated conservatively for fracture stabilization with extension lock splint, and her pain was controlled with the pain medications. She was then discharged home in a stable condition.

Discussion

CLL is a monoclonal disorder characterized by progressive accumulation of functionally incompetent lymphocytes. Usually the early stage of CLL requires no treatment unless the patient is symptomatic or there is a rapid disease progression.[1] Patients with CLL are at high risk of developing common infections (upper and lower respiratory infections), immune system problems, complex/unusual infections, and are at increased risk of developing other cancers.[5-7] Patients with untreated CLL have increased risk of developing spine and pelvic fractures due to altered bone metabolism, resorption, and demineralization.[1,8] However, CLL causing pathological fracture of the long bones is rare.[4] Bony involvement in patients with leukemia is often associated with acute lymphoblastic or acute myeloblastic leukemia.[3] Prior reports of pathological fracture due to CLL involved the spine and vertebral compression fractures and were found to be associated with hypercalcemia.[9-12] Langenberg et al reported a patient who was hypercalcemic and did not show any signs of Richter’s transformation or multiple myeloma on the bone marrow sample but still developed pathological fracture of the distal femur due to CLL.[13] Almost all of the previously reported cases of pathological fracture associated with CLL occurred in the presence of hypercalcemia and were associated with Richter’s transformation or multiple myeloma.[9-16] Review of literature suggests that the exact pathophysiology of the pathological fracture in CLL is not known but may be secondary to locally released osteoclast stimulating factors.[14] It may be appropriate to include pathological long bone fracture in the diagnostic assessment of CLL patients complaining of bone/joint pain.
  14 in total

1.  Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femur.

Authors:  T Robak; M Kasznicki; J Bartkowiak; R Kordek; E Wawrzyniak; J Z Błonski
Journal:  Leuk Lymphoma       Date:  2001-08

2.  Disease-specific complications of chronic lymphocytic leukemia.

Authors:  Claire Dearden
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2008

3.  Bilateral fracture of the mandible in chronic lymphocytic leukaemia. Case report.

Authors:  G W Wright; D Wiesenfeld; J F Seymour
Journal:  Aust Dent J       Date:  1997-02       Impact factor: 2.291

Review 4.  Autoimmune complications in chronic lymphocytic leukaemia (CLL).

Authors:  Clive S Zent; Neil E Kay
Journal:  Best Pract Res Clin Haematol       Date:  2010-03       Impact factor: 3.020

5.  Increased risk of axial fractures in patients with untreated chronic lymphocytic leukemia: a population-based analysis.

Authors:  Adam J Olszewski; Roee Gutman; Charles B Eaton
Journal:  Haematologica       Date:  2016-08-04       Impact factor: 9.941

6.  A case of chronic lymphocytic leukaemia.

Authors: 
Journal:  Br Med J       Date:  1970-02-28

7.  Well-differentiated lymphocytic lymphoma with peripheral blood involvement, osteolytic bone lesions, and hypercalcemia. A case report and review of the literature.

Authors:  S L Abboud; V Gordeuk; L P Schacter; E D Crum; T R Spitzer
Journal:  Cancer       Date:  1985-11-15       Impact factor: 6.860

8.  Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951.

Authors:  Stéphane Ducassou; Céline Ferlay; Christophe Bergeron; Sandrine Girard; Geneviève Laureys; Hélène Pacquement; Dominique Plantaz; Patrick Lutz; Jean-Pierre Vannier; Anna Uyttebroeck; Yves Bertrand
Journal:  Br J Haematol       Date:  2011-01-07       Impact factor: 6.998

9.  Chronic lymphocytic leukemia (CLL) terminating in multiple myeloma: report of two cases.

Authors:  R H Kough; A Z Makary
Journal:  Blood       Date:  1978-09       Impact factor: 22.113

10.  Infectious complications in chronic lymphocytic leukemia.

Authors:  Annamaria Nosari
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-11-05       Impact factor: 2.576

View more
  3 in total

1.  Solitary Lytic Bone Metastasis: A Rare Presentation of Small Lymphocytic Leukemia.

Authors:  Heather Katz; Steven Sagun; Doreen Griswold; Mohamed Alsharedi
Journal:  Case Rep Hematol       Date:  2018-10-30

2.  A case of bone lesion in a patient with relapsed chronic lymphocytic leukemia and review of the literature.

Authors:  Francesca Bacchiarri; Alessandro Gozzetti; Nicola Mondanelli; Stefano Lazzi; Monica Bocchia
Journal:  Clin Case Rep       Date:  2022-04-04

3.  Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines.

Authors:  Paolo Giannoni; Cecilia Marini; Giovanna Cutrona; Serena Matis; Maria Cristina Capra; Francesca Puglisi; Paola Luzzi; Simona Pigozzi; Gabriele Gaggero; Antonino Neri; Katia Todoerti; Fortunato Morabito; Adalberto Ibatici; Maurizio Miglino; Micaela Bergamaschi; Silvia Bruno; Gian Mario Sambuceti; Jean Louis Ravetti; Manlio Ferrarini; Franco Fais; Daniela de Totero
Journal:  Haematologica       Date:  2021-10-01       Impact factor: 9.941

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.